2025-05-05 Drugs The SFDA Approves Breakthrough Designation Application for Breast Cancer Therapy “Inluriyo”
2025-05-04 Drugs The SFDA Approves Clinical Trial for Novel Biologic Therapy for Genetic Propionic Acidemia
2009-12-14 The Authority Early Communication about an Ongoing Safety Review of Reductil (sibutramine hydrochloride)
